Docu Liquid

Product NDC: 17856-0771
11-digit product format: 178560771
Labeler code: 17856
Product ID: 17856-0771_3b3f3045-55db-5ed5-e063-6294a90aab75
Type: HUMAN OTC DRUG
Nonproprietary name: Docusate Sodium
Dosage form: LIQUID
Route: ORAL
Labeler: ATLANTIC BIOLOGICALS CORP.
Application: M
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1997-08-01
Substance: DOCUSATE SODIUM
Active strength: 50 mg/5mL
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	17856-0771	17856-0771-1	D	Discontinued by firm		2026-10-12
excluded package	package	17856-0771	17856-0771-2	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 19 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0771-2	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0771-1	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0771-2	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0771-1	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0771-2	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0771-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0771-2	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0771-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0771-2	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0771-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0771-2	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0771-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0771-2	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0771-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Docu Liquid
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DOCUSATE SODIUM	50 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
F05Q2T2JA0	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1248119	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f4ed0721-3be9-4108-a6c9-dbbe115249e9	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
17856-0771-1	2024-05-24	Drug Facts
17856-0771-2	2024-05-24	Drug Facts
17856-0771-1	2022-01-28	Drug Facts
17856-0771-2	2022-01-28	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17856-0771-1	Docu Liquid	50 in 1 BOX, UNIT-DOSE	LIQUID	50	3
17856-0771-1	Docu Liquid	25 mL in 1 CUP, UNIT-DOSE	LIQUID	25	3
17856-0771-2	Docu Liquid	10 mL in 1 CUP, UNIT-DOSE	LIQUID	10	3
17856-0771-2	Docu Liquid	72 in 1 BOX, UNIT-DOSE	LIQUID	72	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17856-0771-2	ML - Milliliter	17856-0771	c48e96da-0bd0-41c4-8dbf-13b1c32d8db9	1	2022-09-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17856-0771	DOCU LIQUID (DOCUSATE SODIUM) LIQUID [ATLANTIC BIOLOGICALS CORP.]	2	Current NDC, Legacy NDC, 4 package rows	20240526_f4ed0721-3be9-4108-a6c9-dbbe115249e9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 6 · 111 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
First Street Antibacterial Liquid Hand	BENZALKONIUM CHLORIDE	Amerifoods Trading Company	e9d5fefa-970b-42ba-8139-18e564415344	2025-11-06	Warnings	Exact identifier application number: M
Cetirza	CETIRIZINE HCL	HART Health	44b22f6f-5731-4dfe-af33-4e4e54fc3af5	2025-10-06	Warnings	Exact identifier application number: M
Dolce and Gabbana Blueberry Nutri Tint SPF 20 6W Light	ZINC OXIDE	Dolce & Gabbana Beauty S.R.L	d2930d0e-c622-4843-87f2-fa1a92837ff2	2025-09-05	Warnings	Exact identifier application number: M
Alcohol	ISOPROPYL ALCOHOL	NorMed	959815e5-a73b-4905-9d7d-904b33498386	2025-08-15	Warnings	Exact identifier application number: M
TRIBIOTIC	BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	HART Health	c1903b9f-390a-4756-800c-fd93be4182e3	2025-08-13	Warnings, Adverse reactions	Exact identifier application number: M
THERASTAT	CHERRY COUGH DROPS	HART Health	96bae19a-3337-4199-9b8c-cdf9b368178b	2025-08-04	Warnings	Exact identifier application number: M
Docu Liquid	DOCUSATE SODIUM	ATLANTIC BIOLOGICALS CORP.	f4ed0721-3be9-4108-a6c9-dbbe115249e9	2025-07-31	Warnings	Exact identifier application number: M ndc (product): 17856-0771
MINTOX MAXIMUM STRENGTH	ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE	ATLANTIC BIOLOGICALS CORP.	ac6a47e7-972f-4b82-96da-89926d345e9f	2025-07-31	Warnings	Exact identifier application number: M
SENNA	SENNA	ATLANTIC BIOLOGICALS CORP.	8b7cc0d5-029b-43f7-a050-8771e7db4551	2025-07-31	Warnings	Exact identifier application number: M
Stimulant Laxative Plus Stool Softener	DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG	ATLANTIC BIOLOGICALS CORP.	4c02fcec-6bb7-4497-96c5-0d809209dd17	2025-06-27	Warnings	Exact identifier application number: M
Orythia Pain Relieving Lidocaine	LIDOCAINE	Planet (Anhui) Pharmaceutical Co., Ltd.	d658d495-dd2c-40b7-9446-6f10040ed55e	2025-06-27	Warnings	Exact identifier application number: M
Bonica EaseX Pain Relieving	CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE	Planet (Anhui) Pharmaceutical Co., Ltd.	34f1196a-fda1-4bef-be71-e5a09ee97bc1	2025-06-27	Warnings	Exact identifier application number: M
Regular Strength Enteric coated aspirin	ASPIRIN	ATLANTIC BIOLOGICALS CORP.	e1c8d0ed-da1d-4b1a-9a85-7b8532775f87	2025-06-24	Warnings	Exact identifier application number: M
Aspirin Low Dose Chewable Orange	ASPIRIN	ATLANTIC BIOLOGICALS CORP.	a0d8ee59-1ce0-4ddd-a90c-54adb512540c	2025-06-24	Warnings	Exact identifier application number: M
Hydrogen Peroxide	HYDROGEN PEROXIDE	HART Health	f50af223-ba83-458a-a557-1ba5dc221a9c	2025-06-10	Warnings	Exact identifier application number: M
Pharbetol Regular strength	ACETAMINOPHEN	ATLANTIC BIOLOGICALS CORP.	05a91d24-b498-4ba2-a275-68b871cf62d2	2025-06-05	Warnings	Exact identifier application number: M
TEENY TUMMY Gas Relief Drops	SIMETHICONE	ATLANTIC BIOLOGICALS CORP	376660a2-becb-48cf-a9f5-6a76a8b8ca70	2025-05-30	Warnings	Exact identifier application number: M
Mineral Oil	MINERAL OIL	ATLANTIC BIOLOGICALS CORP.	960502ae-2468-406e-8799-cacb01f2727e	2025-05-23	Warnings	Exact identifier application number: M
Stomach Relief Regular Strength	BISMUTH SUBSALICYLATE	ATLANTIC BIOLOGICALS CORP.	5c02d0ba-91e4-4bd2-ac66-6905323653b2	2025-05-12	Warnings	Exact identifier application number: M
MAX Tussin Cough and Chest Congestion DM Sugar Free	DEXTROMETHORPHAN HBR, GUAIFENESIN	ATLANTIC BIOLOGICALS CORP.	8f496c61-41a6-41ba-80f5-7a5309c4d18b	2025-05-12	Warnings	Exact identifier application number: M

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1248119	docusate sodium 50 MG in 5 mL Oral Suspension	PSN	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 10 MG/ML Oral Suspension	SCD	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 100 MG per 10 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 150 MG per 15 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 50 MG per 5 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	DOSS Sodium 10 MG/ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
17856-0771-1	17856077101	50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0771-1) > 25 mL in 1 CUP, UNIT-DOSE	2020-01-31	0000-00-00	No	No	Current
17856-0771-2	17856077102	72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0771-2) > 10 mL in 1 CUP, UNIT-DOSE	2020-01-31	0000-00-00	No	No	Current